Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Viiv
Pharma
Pfizer unleashes its stake in GSK's ViiV Healthcare for $1.9B
Pfizer has surrendered its 11.7% interest in GSK's ViiV for $1.875B. Shionogi will pick up the shares $2.125B and take a 21.7% stake in ViiV.
Kevin Dunleavy
Jan 20, 2026 10:15am
GSK bolsters case for long-acting HIV PrEP drug Apretude
Oct 16, 2024 1:26pm
New name takes top spot in US patient group reputation ranking
May 14, 2024 10:54am
Pharma's reputation falls as pandemic-era halo slips
Apr 29, 2024 2:00am
Arbitration win over J&J gives Alkermes a $425M boost
Jun 6, 2023 3:23pm
GSK adds Karamo Brown to celebs spreading the word about PrEP
Aug 10, 2022 10:13am
